摘要
非酒精性脂肪肝(NAFLD)是成人最常见的肝病类型,其患病率在世界各国均在上升。该病病理特点是肝脏脂肪堆积,在不饮酒、无病毒感染或其他肝脏疾病的情况下肝脂肪超过5%的肝脏重量。自从NAFLD与肥胖、胰岛素抵抗、糖尿病和血脂改变联系在一起,它被认为是代谢综合征的肝脏表型。NAFLD的发病机制尚未明确,但不同的诱因例如脂质蓄积、胰岛素抵抗、氧化和内质网应激、线粒体功能障碍和炎症均可引发。改变生活方式是构成NAFLD控制的第一要素。营养干预包括低脂和具有较高不饱和脂肪酸的碳水化合物饮食。此外,补充抗氧化和细胞保护剂对减少氧化应激、炎症和纤维化也有效。体育锻炼能减少脂肪合成基因的表达、脂肪堆积或胰岛素抵抗并且提高心肺功能。有氧运动和阻力训练的益处已被发现,甚至在运动停止后也存在。然而,对于营养和运动干预的更多分子和细胞机制任需要更多研究来分析,并确定所需的运动量和其与体重减轻的联系。在这篇文章中,我们提供了涉及NAFLD进展机制的最新综述,并分析了营养干预和体育锻练在这种情况下的预防和治疗益处。
关键词: 锻炼,脂肪,肝,非酒精性脂肪肝,营养干预,皮脂腺病。
Current Molecular Medicine
Title:Understanding Nutritional Interventions and Physical Exercise in Non-Alcoholic Fatty Liver Disease
Volume: 15 Issue: 1
Author(s): R. Ordonez, S. Carbajo-Pescador, J.L. Mauriz and J. Gonzalez-Gallego
Affiliation:
关键词: 锻炼,脂肪,肝,非酒精性脂肪肝,营养干预,皮脂腺病。
摘要: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in adults and its prevalence is rising around the world. This pathology is characterized by accumulation of liver fat, which exceeds 5% of liver weight in absence of alcohol consumption, viral infection or other hepatic etiology. Since NAFLD has been associated with obesity, insulin resistance, diabetes or alteration of lipid profiles, it is considered as the liver manifestation of metabolic syndrome. Pathogenic mechanisms of NAFLD have not been clearly elucidated, but different events such as lipid accumulation, insulin resistance, oxidative and endoplasmic reticulum stress, mitochondrial dysfunction and inflammation are involved. Modifications in lifestyle constitute the first line for the management of NAFLD. Nutritional interventions include low fat and carbohydrate diet with higher polyunsaturated fatty acids ingestion. Moreover, supplementation with antioxidant and cytoprotective agents could be useful to decrease oxidative stress, inflammation and fibrosis. Physical activity enables to reduce the expression of lipogenic genes, fat accumulation, or insulin resistance and improves cardiorespiratory fitness. Benefits have been found following both aerobic exercise and resistance training, and remain even after exercise cessation. However, more studies are required to analyze the molecular and cellular mechanisms involved in nutritional and physical intervention, and to define the volume of activity required and its association with weight loss. In this paper, we offer an updated overview of the mechanisms implicated in the progression of NAFLD, and analyze the beneficial effects of nutritional interventions and physical exercise in the prevention and treatment of this condition.
Export Options
About this article
Cite this article as:
R. Ordonez, S. Carbajo-Pescador, J.L. Mauriz and J. Gonzalez-Gallego , Understanding Nutritional Interventions and Physical Exercise in Non-Alcoholic Fatty Liver Disease, Current Molecular Medicine 2015; 15 (1) . https://dx.doi.org/10.2174/1566524015666150114110551
DOI https://dx.doi.org/10.2174/1566524015666150114110551 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
BPC 157 and Blood Vessels
Current Pharmaceutical Design Mechanisms And Prevention Of TAVI-Related Cerebrovascular Events
Current Pharmaceutical Design siRNA Delivery Using Nanocarriers – An Efficient Tool for Gene Silencing
Current Gene Therapy Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges
Current Topics in Medicinal Chemistry Mitochondria-Targeted Antioxidant Peptides
Current Pharmaceutical Design A Summary of Electrospun Nanofibers as Drug Delivery System: Drugs Loaded and Biopolymers Used as Matrices
Current Drug Delivery Carotid Ultrasound in One, Two and Three Dimensions
Vascular Disease Prevention (Discontinued) Ignored Avenues in Alpha-Synuclein Associated Proteopathy
CNS & Neurological Disorders - Drug Targets Optimal Dosing Design for Antibiotic Therapy in the Elderly: A Pharmacokinetic and Pharmacodynamic Perspective
Recent Patents on Anti-Infective Drug Discovery Hydrogen Sulfide Regulates Vascular Inflammation and its Related Signaling Pathways
Current Signal Transduction Therapy The Need for Diagnostic Criteria in Systemic Vasculitis
Current Immunology Reviews (Discontinued) Meet Our Editorial Board Member:
Applied Clinical Research, Clinical Trials and Regulatory Affairs Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection
Current Drug Metabolism Preventing Vascular Graft Failure: Endothelial Cell Seeding and Tissue Engineering
Vascular Disease Prevention (Discontinued) Recent Progress in Cerebrovascular Gene Therapy
Current Neurovascular Research Estrogenic Compounds, Estrogen Receptors and Vascular Cell Signaling in the Aging Blood Vessels
Current Medicinal Chemistry Significance of P2X7 Receptor Variants to Human Health and Disease
Recent Patents on DNA & Gene Sequences Polypharmacology in a Single Drug: Multitarget Drugs
Current Medicinal Chemistry Cartilage and Bone Extracellular Matrix
Current Pharmaceutical Design Therapy of Chronic Hepatitis C Virus Infection in HIV Co-Infected People
Current Pharmaceutical Design